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Abstract
Introduction: Mild hypoglycemia is associated with increased mortality in critically ill patients. However, data regarding
the association between mild hypoglycemia and patient outcomes among patients with sepsis are limited.
Methods: Patients admitted to a medical ICU for sepsis, as defined by the Surviving Sepsis Campaign guidelines,
during a 3-year period were enrolled retrospectively. Data on blood glucose (BG) control parameters and patient
outcomes were collected. The primary outcome was the relationship of mild hypoglycemia (defined as minimum
BG of 40 to 69 mg/dl during ICU stay) to hospital mortality, and the secondary outcomes were ICU-acquired
complication rates, ICU and 1-year mortality rates. A relationship between glucose variability and hypoglycemic
events was also investigated.
Results: Three-hundred and thirteen consecutive patients with sepsis were enrolled (mean age, 71.8 ± 11.3 years;
male, n = 166; diabetics, n = 102). A total of 14,249 (5.6/day/patient) BG tests were performed, and 175
hypoglycemic events (spontaneous, n = 71; iatrogenic, n = 104) occurred in 80 (25.6%) patients during the ICU
stay; severe hypoglycemia (minimum BG level < 40 mg/dl) occurred in 24 (7.7%) patients, and mild hypoglycemia
(minimum BG level 40 to 69 mg/dl) was found in 56 (17.9%) patients. The frequency of hypoglycemic events
increased with higher glucose variability, and patients with mild hypoglycemia had higher rates of ICU-acquired
complications than did those with no hypoglycemia (renal, 36.2% vs. 15.6%, P = 0.003; cardiac, 31.9% vs. 14.3%,
P = 0.008; hepatic, 34.0% vs. 18.2%, P = 0.024; bacteremia, 14.9% vs. 4.5%, P = 0.021). Multivariate analysis revealed
that mild hypoglycemia was independently associated with increased hospital mortality (odds ratio, 3.43; 95%
confidence interval, 1.51 to 7.82), and even a single event was an independent risk factor (odds ratio, 2.98; 95%
confidence interval, 1.10 to 8.09). Kaplan-Meier analysis demonstrated that mild hypoglycemia was significantly
associated with a lower 1-year cumulative survival rate among patients with sepsis (P < 0.001).
Conclusion: Mild hypoglycemia was associated with increased risk of hospital and 1-year mortality, as well as the
occurrence of ICU-acquired complications. Physicians thus need to recognize the importance of mild hypoglycemia
in patients with sepsis.
Introduction
Since van den Berghe and colleagues demonstrated in the
second Leuven study that severe hypoglycemia (blood
glucose (BG) < 40 mg/dl) is associated with mortality [1],
subsequent multicentre studies (Efficacy of Volume
Substitution and Insulin Therapy in Severe Sepsis
(VISEP) and GLUCONTROL trials) have identified a
high rate of severe hypoglycemic events among intensive
insulin treatment (IIT) groups (target, 80 to 110 mg/dl)
[2,3]. In addition, several large observational studies have
shown that severe hypoglycemia is an independent risk
factor for mortality [4-6].
Several recent studies have demonstrated the relation-
ship between mild hypoglycemia and increased mortality
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rate in critically ill patients. Egi and colleagues reported
that patients with mild hypoglycemia had an increased
unadjusted mortality rate [7], and Krinsley and collea-
gues also demonstrated a strong association between
mild hypoglycemia and increased mortality [8]. The
American Diabetes Association revised the definition of
hypoglycemia as BG < 70 mg/dl in 2010 [9]. Physicians
should thus be cautious of mild hypoglycemic events
when treating critically ill patients.
Glucose control may be difficult in patients with sep-
sis because of frequent hypoglycemic and hyperglyce-
mic events, which can have detrimental effects on
hospital outcomes [10-12]. Although many glucose
control studies have included patients with sepsis
[2,3,7,13], the importance of hypoglycemia among
patients with sepsis has been addressed by only a few
studies [11,14]. In particular, data on mild hypoglyce-
mia are limited. The primary objective of this study
was therefore to investigate the association between
mild hypoglycemia (BG 40 to 69 mg/dl) and hospital
mortality, and the secondary objectives were to investi-
gate its relationship with the ICU-acquired complica-




Patients who were admitted to the medical ICU for sepsis
at Hallym University Sacred Heart Hospital between Jan-
uary 2008 and December 2010 were enrolled in our
study. The 2008 Surviving Sepsis Campaign guidelines
were used to diagnose sepsis [15]. We collected data
anonymously from electronic medical records and ana-
lyzed them retrospectively. Initially, 403 adult patients
were screened for participation in the study. Patients who
had daily BG tests and at least four BG tests during their
ICU stay were included in the study, and 90 patients
were excluded based on the exclusion criteria (Figure 1).
The institutional review board at Hallym University
Sacred Heart Hospital approved the present study (IRB
No. 2012-I006) and waived the necessity to obtain writ-
ten consent because of its retrospective nature.
Data collection
We collected data regarding age, sex, co-morbidities,
laboratory parameters, Simplified Acute Physiology
Score (SAPS) II and ICU treatments (that is, insulin, any
dose of systemic steroid, mechanical ventilation, renal
replacement therapy). In addition to ICU-acquired com-
plications occurring after ICU day 3, we investigated
hospital, ICU, and 30-day mortalities and 1-year cumu-
lative survival rates.
Various BG control parameters during the ICU stay
were calculated for each patient as follows: frequency of
BG tests (total and daily mean frequencies); mean BG
levels; number of severe hypoglycemia (BG < 40 mg/dl)
and mild hypoglycemia (BG 40 to 69 mg/dl) events; and
three glucose variability (GV) parameters (standard
deviation (SD) of mean BG levels, coefficient of variation
(SD of mean BG/mean BG), and Hermanides’ metric for
GV) [16]
We investigated the occurrence of ICU-acquired com-
plications occurring after ICU day 3 (that is, renal, car-
diac, hepatic and respiratory complications, and
bacteremia). Renal complications were defined as: an
increase in serum creatinine levels of at least twofold
over baseline levels; progression of oliguria (urine output
< 500 ml in 24 hours or < 0.5 ml/kg/hour); or initiation
of renal replacement therapy.
Cardiac complications were defined as: an ischemic
event indicated by an increase in cardiac markers (tro-
ponin I and creatine kinase-MB) and significant electro-
cardiogram changes indicative of sustained new
ischemia (ST-segment depression or elevation, new
pathologic Q waves, and T-wave abnormalities in at
least two consecutive leads); fatal arrhythmia (ventricu-
lar tachycardia or ventricular fibrillation); or sudden car-
diac arrest.
Hepatic complications were defined as: greater than
twofold increase in total bilirubin over baseline levels
(and at least > 4 mg/dl); or increase in aspartate amino-
transferase or alanine aminotrasferase > 1,000 IU/l with
a rise in the prothrombin time (international normalized
time > 2).
Respiratory complications were defined as: develop-
ment of acute respiratory distress syndrome [17]; venti-
lator-associated pneumonia [18]; or initiation of
mechanical ventilation after 3 ICU days, excluding cases
of reintubation resulting from extubation failure.
Finally, bacteremia was defined as at least two positive
blood culture results, excluding isolation of coagulase-
negative Staphylococcus.
Figure 1 Flow chart of patient enrolment. BG, blood glucose;
CPR, cardiopulmonary resuscitation.
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Blood glucose control and monitoring in the ICU
In our medical ICU, BG controls were conducted using an
insulin protocol (Additional file 1) that was modified
according to the Surviving Sepsis Campaign guidelines
[15,19]. The target for BG control was 70 to 150 mg/dl,
and BG levels in arterial or capillary blood were measured
using a bedside glucose meter (LifeScan, Inc., Milpitas,
CA, USA). Patients received a continuous intravenous
insulin infusion when BG levels were > 150 mg/dl. One
unit of regular human insulin per 1 ml of 0.9% NaCl was
administered, and the insulin dose was adjusted to main-
tain the target BG level. BG values were initially monitored
every 1 to 2 hours until glucose values and insulin infusion
rates were stable, and then every 4 to 6 hours thereafter.
Data analyses
The primary outcome of the present study was the associa-
tion between mild hypoglycemia and hospital mortality.
The secondary outcomes included a comparison of ICU-
acquired complication rates, and ICU and 30-day and
1-year mortalities between patients with and without mild
hypoglycemia. Risk factors for hypoglycemic events were
investigated, and the proportion of patients who experi-
enced hypoglycemic events were also compared among the
quartile groups of BG control parameters (that is, mean
BG, SD, coefficient of variation, and Hermanides’ metric).
Data are expressed as mean (standard deviation) or
median (interquartile range) as appropriate for continuous
data and as percentages for categorical data. For continu-
ous data, Student’s t test or the Mann-Whitney U test was
used when comparing two groups and analysis of variance
or the Kruskal-Wallis test was used when comparing three
groups. The chi-squared test or Fisher’s exact test was
used for categorical data; however, when comparing two
groups from the hypoglycemia groups (that is, mild hypo-
glycemia vs. no hypoglycemia; severe hypoglycemia vs. no
hypoglycemia), logistic regression analysis was used in
which the hypoglycemia variable was categorized into
three groups. To identify risk factors for hospital mortality
and hypoglycemic events, multivariate logistic regression
analyses were performed using covariates with P < 0.05 in
the univariate analyses. A backward stepwise analysis
(based on the likelihood ratio) was used, with P = 0.05 to
enter and P = 0.10 to stay in the model. The Kaplan-Meier
method with the log-rank test was used to analyze 1-year
survival rates. All reported P values were two-sided, and
P < 0.05 was considered statistically significant. All ana-
lyses were conducted using SAS statistical software, EG
version (SAS Institute, Inc., Cary, NC, USA).
Results
Study population
The mean age of the enrolled patients (n = 313) was
71.8 ± 11.3 years, and 166 were male (Table 1). A
history of smoking was found for 74 (23.6%) patients,
and diabetes (n = 102, 32.6%) and hypertension (n =
125, 39.9%) were the most common co-morbid illnesses
(cancer, n = 63; cerebrovascular accidents, n = 53;
chronic heart disease, n = 35; chronic kidney disease,
n = 36; liver cirrhosis, n = 14; chronic obstructive pul-
monary disease/bronchial asthma, n = 25).
Septic shock accounted for 59.4% of the patients (n =
186; severe sepsis, n = 99; sepsis, n = 28), and among the
sepsis origins pneumonia (n = 171, 54.6%) was the most
common (urinary tract, n = 58; hepatobiliary, n = 55;
intra-abdominal, n = 14; soft tissue and skin, n = 8; bac-
teremia, n = 3; meningitis, n = 2; unidentified, n = 2).
Insulin therapy was conducted in 83 (81.4%) diabetics
(vs. 120 (56.9%) nondiabetics).
Blood glucose measurements, hypoglycemic events, and
risk factors
The total number of BG tests performed in all enrolled
patients during their ICU stay was 14,249, and the med-
ian (interquartile range) number of BG tests per day per
patient was 5.6 (4.4 to 7.0). The median value of indivi-
dual mean BG levels was 177.3 mg/dl (148.8 to 205.6
mg/dl). The median values for the SD, coefficient of var-
iation, and Hermanides’ metric were 48.4 mg/dl (33.6 to
71.0 mg/dl), 27.6% (20.0 to 36.5%), and 7.4 mg/dl (4.9 to
11.8 mg/dl), respectively. In total, 175 hypoglycemic
events (BG < 70 mg/dl) occurred in 80 (25.6%) patients.
Among these, 71 (40.6%) hypoglycemic events occurred
spontaneously and 104 (59.4%) occurred with insulin
therapy (that is, iatrogenic hypoglycemia). A total of 83
(47.4%) events occurred in conscious patients and 92
(52.6%) events occurred in unconscious patients. Among
the 80 hypoglycemic patients, 56 had a minimum BG
level of 40 to 69 mg/dl (that is, mild hypoglycemia) and
24 had a minimum BG level < 40 mg/dl (that is, severe
hypoglycemia); 13 patients had both mild and severe
hypoglycemia during their ICU stay.
When the patients were stratified based on their mini-
mum BG levels, the frequency of diabetes and insulin
treatment, SAPS II, SD of the mean BG, coefficient of
variation, and Hermanides’ metric were higher in the two
hypoglycemic groups as compared with patients without
hypoglycemia (Table 1). The frequency of hypoglycemic
events tended to increase in patients with higher GV
parameters (Figure 2).
The univariate analyses revealed 16 variables - diabetes,
hematocrit, lactate, serum albumin, brain natriuretic pep-
tide, creatine kinase-MB, GV parameters (SD of mean
BG, coefficient of variation, Hermanides’ metric), SAPS
II, insulin therapy, vasopressor, mechanical ventilation,
renal replacement therapy, hepatic failure, and ventilator-
associated pneumonia - that were significantly associated
with hypoglycemic events (P < 0.05). Multivariate logistic
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analysis included 14 variables; of the three GV para-
meters, only the SD of mean BG was included in the
model. Among the variables included in the final model,
diabetes, hematocrit, lactate, SD of mean BG, hepatic fail-
ure, and ventilator-associated pneumonia were indepen-
dent risk factors for hypoglycemic events (Table 2).
Mild hypoglycemic events and the occurrence of ICU-
acquired complications
We investigated the occurrence of ICU-acquired compli-
cations among 219 patients who stayed in the ICU for
more than 3 days, and 202 complications occurred in 116
(53%) patients (renal, n = 47; cardiac, n = 35; hepatic, n =
50; respiratory, n = 53; bacteriemia, n = 17; Figure 3).
The complication rates were higher in both hypoglycemic
groups (mild hypoglycemia, 33/47; severe hypoglycemia,
15/18) as compared with patients without hypoglycemia
(68/154; P = 0.002 and P = 0.005, respectively). The fre-
quencies of renal, cardiac, and hepatic complications and
bacteremia were higher in patients with mild hypoglyce-
mia as compared with those who were not hypoglycemic
(36.2% vs. 15.6%, P = 0.003; 31.9% vs. 14.3%, P = 0.008;
34.0% vs. 18.2%, P = 0.024; and 14.9% vs. 4.5%, P = 0.021,
respectively). Among 48 patients with both hypoglycemia
Table 1 Glucose control parameters, treatments, and outcomes among enrolled patients stratified by minimum blood
glucose levels
Minimum blood glucose level P valuea
< 40 mg/dl (n = 24) 40 to 69 mg/dl (n = 56) ≥ 70 mg/dl (n = 233)
Age 71.9 ± 11.2 69.3 ± 12.6 72.4 ± 11.0 0.177b
Male/female 11/13 34/22 121/112 0.379c
Diabetes 10 (41.7%) 31 (55.4%) 61 (26.2%) < 0.001c
Admission SAPS II 57 ± 15.9 52.2 ± 14.0 46.4 ± 13.1 < 0.001b
Laboratory parameters
WBC (mm3) 11,550 (6,950 to 20,775) 13,450 (6,225 to 20,075) 14,300 (8,850 to 21,050) 0.053d
Hematocrit (%) 32.2 ± 6.0 31.1 ± 7.8 34.8 ± 6.7 0.001b
Platelet (×103 mm3) 166.0 (73.8 to 268.3) 190.0 (101.0 to 288.3) 209.0 (121.0 to 288.0) 0.320d
Lactate (mmol/l) 4.8 (3.5 to 8.6) 4.5 (2.6 to 7.0) 3.5 (2.3 to 5.6) 0.013d
Serum albumin (g/dl) 2.9 ± 0.6 3.0 ± 0.6 3.2 ± 0.6 0.020b
Blood urea nitrogen (mg/dl) 28.3 (17.8 to 41.3) 36.6 (18.1 to 50.7) 25.6 (16.4 to 42.3) 0.237d
Creatinine (mg/dl) 1.1 (0.7 to 2.5) 1.3 (0.9 to 2.3) 1.2 (0.8 to 1.9) 0.345d
Total bilirubin (mg/dl) 0.9 (0.6 to 1.4) 0.9 (0.5 to 1.7) 0.9 (0.6 to 1.9) 0.744d
BNP (pg/ml) 554.4 (207.3 to 1205.4) 347.3 (133.8 to 1377.4) 251.9 (138.8 to 638.2) 0.029d
CK-MB (ng/ml) 3.9 (2.0 to 7.9) 2.3 (1.3 to 8.2) 2.0 (0.9 to 4.95) 0.023d
C-reactive protein (mg/l) 170.9 (77.3 to 232.1) 142.0 (86.9 to 225.0) 157.0 (81.6 to 239.5) 0.931d
BG control parameters
Number of BG tests (/day/patient) 6.3 (4.9 to 9.9) 6.4 (5.0 to 7.9) 5.2 (4.3 to 6.7) < 0.001d
Mean BG (mg/dl)e 163.9 (146.0 to 194.3) 189.3 (166.9 to 208.1) 174.6 (145.0 to 205.9) 0.096d
Median SD (mg/dl) 73.1 (48.9 to 116.2) 71.3 (46.1 to 92.9) 42.1 (30.5 to 62.0) < 0.001d
Median CV (%) 41.6 (29.4 to 56.5) 37.6 (29.2 to 45.2) 24.2 (18.9 to 31.8) < 0.001d
Hermanides’ metric (mg/dl) 11.9 (6.9 to 22.1) 11.7 (8.0 to 16.0) 6.6 (4.5 to 9.6) < 0.001d
Insulin therapy 18 (75.0%) 43 (76.8%) 142 (60.9%) 0.015c, f
Systemic steroid therapy 9 (37.5%) 26 (46.4%) 91 (39.1%) 0.576c, f
Vasopressors 23 (95.8%) 45 (80.4%) 166 (71.2%) 0.017c, f
Mechanical ventilation 23 (95.8%) 40 (71.4%) 132 (56.7%) < 0.001c, f
VAP 3 (12.5%) 6 (10.7%) 7 (3.0%) 0.015c, f
Renal replacement therapy 5 (20.8%) 11 (19.6%) 25 (10.7%) 0.150c
Length of ICU stay (days) 11.5 (3.3-19.8) 7.0 (5.0-14.0) 5.0 (3.0-9.0) < 0.001d
ICU mortality 18/24 (75.0%) 34/56 (60.7%) 66/233 (28.3%) < 0.001c, f
Hospital mortality 19/24 (79.2%) 37/56 (66.1%) 71/233 (30.5%) < 0.001c, f
30-day mortality 18/24 (75.0%) 34/55 (61.8%) 69/230 (30.0%) < 0.001c, f
1-year mortality 21/24 (87.5%) 41/55 (74.5%) 107/230 (46.5%) < 0.001c, f
Continuous data expressed as mean ± standard deviation or median (interquartile range) and categorical data expressed as number (%). BG, blood glucose; BNP,
brain natriuretic peptide; CK-MB, creatine kinase-MB; CV, coefficient of variation; SAPS, Simplified Acute Physiology Score; SD, standard deviation; VAP, ventilator-
associated pneumonia; WBC, white blood cell. aComparisons among three groups (that is, < 40 mg/dl vs. 40 to 69 mg/dl vs. ≥ 70 mg/dl). bAnalysis of variance.
cChi-squared test. dKruskal-Wallis test. eMedian values of individual mean BG levels. fP < 0.05 by linear-by-linear association.
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and ICU-acquired complications, hypoglycemic events
occurred prior to ICU-acquired complications in 31
patients.
Mild hypoglycemia and mortality
The ICU, hospital, 30-day, and 1-year mortalities were
higher in patients with mild hypoglycemia compared
with those without hypoglycemia. We found an increas-
ing trend of mortality in patients with increasing severity
of hypoglycemia (Table 1). Furthermore, we observed a
trend of increasing mortality in patients with the highest
frequency (0 vs. 1 to 2 vs. ≥ 3) of hypoglycemia events,
irrespective of whether the hypoglycemia was mild or
severe (Additional file 2). We also found no significant
differences between spontaneous and iatrogenic hypogly-
cemia in terms of the time from ICU admission to hypo-
glycemic event, time from hypoglycemic event to hospital
death, and hospital mortality rate (Table 3).
In the multivariate analysis, 16 variables significant at
P < 0.05 in the univariate analyses (Additional file 3)
were initially included. Among the three GV parameters,
the SD of the mean BG was the only variable included
in the model, and the hypoglycemia variable was cate-
gorized into three groups based on minimum BG levels.
In the final model (Table 4), mild hypoglycemia was sig-
nificantly associated with increased hospital mortality
(odds ratio, 3.43; 95% confidence interval, 1.51 to 7.82).
We performed a further multivariate analysis in patients
who experienced no or one mild hypoglycemic event
(n = 233 and 32, respectively; Additional file 4) and
determined that a single mild hypoglycemic event was
significantly associated with increased hospital mortality
(OR, 2.98; 95% confidence interval, 1.10 to 8.09).
The overall survival rate for all enrolled patients was
45.3% (140/309) at 1 year; four patients were lost to the
1-year follow-up. Mean survival times were 225.8 ± 10.9
days, 111.1 ± 20.4 days, and 66.6 ± 24.0 days in patients
with no hypoglycemia, mild hypoglycemia, and severe
hypoglycemia, respectively (Figure 4). The 1-year survival
rates were significantly lower in the mild and severe
hypoglycemic groups compared with patients without
hypoglycemia, and no significant difference was observed
between the two hypoglycemia groups.
Discussion
The present study identified several important findings in
patients with sepsis. First, mild hypoglycemia (defined as
BG 40 to 69 mg/dl) was significantly associated with
increased hospital mortality, and even a single mild hypo-
glycemic event showed a significant association. Second,
Figure 2 Frequencies of hypoglycemia during ICU stay
stratified by quartiles of glucose control parameters. Quartile
ranges of mean blood glucose (BG): < 148.8, 148.8 to 177.3, 177.3 to
205.6, and > 205.6 mg/dl. Quartile ranges of standard deviation (SD):
< 33.6, 33.6 to 48.4, 48.4 to 71.0, and > 71.0 mg/dl. Quartile ranges
of coefficient of variation (CV): < 20.0%, 20.0 to 27.6%, 27.6 to 36.5%,
and > 36.5%. Quartile ranges of Hermanides’ metric: < 4.9, 4.9 to
7.4, 7.4 to 11.8, and > 11.8 mg/dl. aP < 0.001 (chi-squared test), bP <
0.001 (linear-by-linear association) among the quartile groups.
Table 2 Multivariate analysis of risk factors for
hypoglycemic events
Variable Odds ratio 95% confidence interval P value
Diabetes 2.60 1.30 to 5.17 0.007
Hematocrit (%) 0.91 0.87 to 0.96 0.001
Lactate (mmol/l) 1.11 1.02 to 1.21 0.017
CK-MB (ng/ml) 1.02 1.00 to 1.05 0.050
SD of mean BG 1.03 1.02 to 1.04 < 0.001
Hepatic failure 3.63 1.52 to 8.67 0.004
VAP 11.39 3.43 to 37.85 < 0.001
BG, blood glucose; CK-MB, creatine kinase-MB; SD, standard deviation; VAP,
ventilator-associated pneumonia. Chi-square = 5.336 and P = 0.721 by
Hosmer-Lemeshow goodness-of-fit test.
Figure 3 Frequency of ICU-acquired complications in patients
with ICU stay > 3 days. Data stratified by minimum blood glucose
(BG) levels. The frequencies of renal, cardiac, and hepatic
complications and bacteremia were significantly higher in patients
with mild hypoglycemia as compared with those without
hypoglycemia. aComparisons between patients with mild
hypoglycemia and those without hypoglycemia. bComparisons
between patients with severe hypoglycemia and those without
hypoglycemia.
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mild hypoglycemia was significantly associated with a
lower 1-year cumulative survival rate. Third, mild hypo-
glycemia was associated with a high rate of ICU-acquired
complications during the ICU stay.
Glucose control in patients with sepsis can be challen-
ging because they are vulnerable to hyperglycemia and
hypoglycemia, which result in high GV [10-12]. In the pre-
sent study, the median value of individual mean BG levels
(177.3 mg/dl (148.8 to 205.6 mg/dl)) suggested that BG
was not well controlled, and insulin treatment was inade-
quate in patients with sepsis. However, the rate of hypo-
glycemia was high. In a study by Bagshaw and colleagues,
the incidence of mild hypoglycemia was 6.2% in all
patients and 8.6% among the sepsis subgroup [4]. The
authors reported that the adjusted odds ratio for hospital
mortality was 1.6 (95% confidence interval, 1.4 to 1.8). Egi
and colleagues [7] and Krinsley and colleagues [8], more
specifically, identified that mild hypoglycemia had a
greater than twofold increase in the odds of hospital
mortality. These previous studies targeted all ICU patients.
However, we focused on patients with sepsis and noticed
that even a single mild hypoglycemic event was associated
with a nearly threefold increase in hospital mortality. In
particular, when we stratified sepsis patients by tertile
groups of SAPS II, patients with mild hypoglycemia
showed a higher mortality rate than those without hypo-
glycemia in each tertile group (Additional file 5). This
finding suggests that mild hypoglycemia per se is asso-
ciated with patient outcomes independent of disease sever-
ity. However, the multivariate analysis did not reveal a
significant association between severe hypoglycemia and
mortality. We believe that the small number of patients
with severe hypoglycemia in our study may, in part,
account for this finding. A future study with a larger num-
ber of patients is thus needed to clarify this point.
We demonstrated that the long-term survival rate was
significantly lower in patients with sepsis who experi-
enced mild hypoglycemia as compared with patients with
sepsis who were not hypoglycemic (Figure 4). Although
the authors of the Normoglycaemia in Intensive Care
Evaluation - Surviving Using Glucose Algorithm Regula-
tion (NICE-SUGAR) trial noticed that severe hypoglyce-
mia was more frequent and that 90-day mortality was
higher in the IIT group [13], the long-term prognosis of
patients with hypoglycemia has not been well studied.
The NICE-SUGAR trial found no difference between the
IIT and conventional-therapy groups in rates of new
organ failure; however, death from cardiovascular causes
Table 3 Comparisons of time to events and time to hospital deaths among three hypoglycemic groups
Variable Spontaneous hypoglycemia
(patient n = 32)
Iatrogenic hypoglycemia
(patient n = 41)
Both hypoglycemias
(patient n = 7)
P
valuea
Total number of hypoglycemic events 61 81 33b
Hospital deaths 22 (68.8%) 28 (68.3%) 6 (85.7%) 0.967c
Time from ICU admission to first
hypoglycemic event (days)
3.0 (1.0 to 5.8) 3.0 (1.0 to 5.5) 1.0 (6 hours to 4.0) 0.490d
Time from first hypoglycemic event to
hospital death (days)
3.0 (1.0 to 12.0) 5.0 (1.0 to 11.5) 13.5 (6.0 to 26.5) 0.898d
aComparisons between two groups (that is, spontaneous hypoglycemia vs. iatrogenic hypoglycemia). bTen hypoglycemic events occurred spontaneously. cChi-
squared test. dMann-Whitney U test.
Table 4 Multivariate analysis of risk factors for hospital







Cancer 2.82 1.24 to 6.41 0.014
Serum albumin (mg/dl) 0.34 0.19 to 0.62 < 0.001
Admission SAPS II 1.03 1.00 to 1.06 0.027
Vasopressors 2.15 0.85 to 5.41 0.105
Mechanical ventilation 3.56 1.61 to 7.85 0.002
Hepatic failure 18.27 3.90 to 85.61 < 0.001
VAP 11.33 2.03 to 63.30 0.006
Hypoglycemic events 0.009
Mild hypoglycemia 3.43 1.51 to 7.82 0.003
Severe
hypoglycemia
2.17 0.59 to 7.94 0.244
SAPS, Simplified Acute Physiology Score; VAP: ventilator-associated
pneumonia. Chi-square = 4.826 and P = 0.776 by Hosmer-Lemeshow
goodness-of-fit test.
Figure 4 Kaplan-Meier survival analyses for 1-year cumulative
survival rates. Among the three hypoglycemia groups, patients
with mild hypoglycemia had a significantly lower 1-year survival rate
than did patients without hypoglycemia. BG, blood glucose. aP <
0.001, bP = 0.127 vs. severe hypoglycemia.
Park et al. Critical Care 2012, 16:R189
http://ccforum.com/content/16/5/R189
Page 6 of 9
was more common in the IIT group. The present study
found that mild hypoglycemia was associated with
increased rates of renal, cardiac, and hepatic complica-
tions and bacteremia. Although the definitions for the
ICU-acquired complications in the present study were
different from those used in the VISEP and NICE-
SUGAR trials [2,13], our results are additive to those of
previous studies.
GV parameters are associated with hypoglycemia and
mortality [10,20]. The results of the present study show
that the SD of mean BG levels, one of three GV para-
meters, was a significant risk factor for hypoglycemia.
GV-reduction strategies may thus be critical for decreas-
ing hypoglycemic events and hospital mortality [20]. We
also identified other risk factors for hypoglycemia such
as diabetes, hematocrit, lactate, hepatic failure, and ven-
tilator-associated pneumonia; however, previous studies
have found renal failure, renal replacement therapy, and
the use of vasopressors to be risk factors [6,10].
Although physicians must take care in the management
of patients with these risk factors, it is important that
they recognize that hypoglycemia may simply represent
a marker of worsening organ function [21].
Several factors may explain the relationship between
hypoglycemia and patient outcomes [21]. During critical
illnesses, the physiological responses induced by hypogly-
cemia, such as the inhibition of insulin release and
increased release of glucagon, epinephrine, growth hor-
mone, and cortisol, are frequently impaired [22,23]. Sec-
ond, the large amount of glucose administered to patients
with hypoglycemia may be associated with cellular damage
[24]. Third, hypoglycemia may cause biological toxicities,
such as an increased systemic inflammatory response [25],
cerebral vasodilation [26], and neuroglycopenia [27]. In
particular, severe hypoglycemia causes an increase in
extracellular glutamate and results in excitotoxicity [28].
However, as mentioned previously, hypoglycemia may be
a marker of increasing disease severity or impending death
[21]. Although we demonstrated that mild hypoglycemia
was an independent risk factor for hospital mortality, the
causal relationship is not clear.
The present study had several limitations. First, it was a
retrospective study, and the number of patients was lim-
ited. The data may thus reflect unintended bias. Second,
capillary blood sampling was performed in a percentage
of patients using a bedside glucose analyzer, which may
be associated with analytic inaccuracies in critically ill
patients [29-31]. However, this measurement is typically
used in the ICU setting. Third, BG control in this investi-
gation was challenging, reflected by the fact that the low-
est quartile of the mean BG was < 148.8 mg/dl, while the
glycemic target was < 150 mg/dl. Fourth, although we
analyzed the association between the frequency of hypo-
glycemia and mortality, intermittent monitoring of BG in
the present study may have led to undetected hypoglyce-
mic events. Fifth, we could not investigate the insulin
dosage or nutritional support (that is, calorie intake),
which can impact hypoglycemic events and patient
outcomes.
Despite these limitations, our study has several major
strengths. First, in contrast to previous studies, we
focused on mild hypoglycemic events in patients with
sepsis. Although the causal relationship is unclear, a sin-
gle mild hypoglycemic event may be harmful to patients.
Second, we performed various analyses to elucidate the
relationship between mild hypoglycemia and patient
outcome. In particular, although this is a retrospective
study, we obtained 1-year survival data for most of the
patients (98.7%), which we think provide credible evi-
dence regarding long-term outcome. Future large-scale,
prospective studies of patients with hypoglycemia are
necessary to clarify the relationship between mild hypo-
glycemia and patient outcome. Furthermore, considera-
tion of hypoglycemic conditions (spontaneous vs.
iatrogenic hypoglycemia) and diabetic status is also
likely to yield intriguing results.
Conclusion
Mild hypoglycemia was associated with increased hospi-
tal and 1-year mortality in patients with sepsis. Further-
more, it was also associated with an increased rate of
ICU-acquired complications. Physicians must thus be
aware of the importance of mild hypoglycemia in
patients with sepsis.
Key messages
• Mild hypoglycemia, defined as a BG of 40 to 69
mg/dl, was significantly associated with increased
hospital mortality, and even a single mild hypoglyce-
mic event was an independent risk factor.
• Mild hypoglycemia was significantly associated
with a lower 1-year cumulative survival rate among
patients with sepsis.
• Mild hypoglycemia was associated with a high rate
of ICU-acquired complications during the ICU stay
in patients with sepsis.
Additional material
Additional file 1: a diagram showing the glycemic control protocol
(Hallym University Sacred Heart Hospital).
Additional file 2: a figure showing the associations between the
number of hypoglycemic events (0 vs. 1 to 2 vs. ≥ 3 hypoglycemia
events) and hospital mortality.
Additional file 3: a table presenting the univariate analyses of risk
factors for hospital mortality.
Additional file 4: a table presenting the multivariate analysis of risk
factors for hospital mortality among patients with 0 or 1 episode of
mild hypoglycemia.
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Additional file 5: a figure showing the relationship between
hypoglycemia and hospital mortality, stratified by SAPS II tertiles.
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